David S. Perlin, Ph.D. is Chief Scientific Officer and Senior Vice President of the Center for Discovery and Innovation; Professor of Medical Sciences at the Hackensack Meridian School of Medicine at Seton Hall University; Fellow of the New York Academy of Sciences; and Fellow of the American Academy of Microbiology.
His research emphasizes studies to diagnose and overcome drug-resistant fungal and bacterial infections in cancer, transplant and other high-risk patients by exploiting insights obtained from molecular investigations of drug resistance, pathogenicity, and host response to improve current therapies and develop novel drugs and diagnostics.